Petrillo, Angelica
Pappalardo, Annalisa
Pompella, Luca
Tirino, Giuseppe
Calabrese, Filomena
Laterza, Maria Maddalena
Caterino, Marianna
Ventriglia, Anna
Orditura, Michele
Conzo, Giovanni
Molino, Carlo
Ciardiello, Fortunato
Biglietto, Maria
De Vita, Ferdinando http://orcid.org/0000-0002-7654-7470
Article History
Received: 22 June 2019
Accepted: 15 August 2019
First Online: 23 August 2019
Compliance with ethical standards
:
: A.Pe: honoraria from Lilly; M.O: Honoraria from Italfarmaco, EISAI, epionpharma, Roche; F.Ci: Advisory Boards: Roche, Amgen, Merck, Pfizer, Sanofi, Bayer, Servier, BMS, Celgene, Lilly; Institutional Research Grants: Bayer, Roche, Merck, Amgen, AstraZeneca, Takeda; F.D.V: Advisory Boards: Roche, Amgen, Celgene, Lilly. The authors declare that all these conflicts of interest are not connected with the issue of this paper. The other authors have no conflicts of interest to declare.
: All patients, at the time of therapy, signed informed consent about the use of their data for future medical research. The analysis was carried out with the approval of Ethics Committee of AOU “Luigi Vanvitelli”—AORN Ospedali dei Colli, of our institution.